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a  b  s  t  r  a  c  t
Pancreatic  tumors  comprise  benign  lesion  and  malignant  lesion,  most  importantly  pancreatic  adenocar-
cinoma,  acinar  cell  carcinoma,  neuroendocrine  carcinoma  or metastasis.  Surgical  resection  provides  the
only  chance  for  cure  for malignant  pancreatic  tumors.  In some  cases,  surgical  resection  is performed
because  a malignant  lesion  is suspected,  however,  histopathological  examinations  eventually  reveal  a
benign lesion.  Here,  we report  the  case  of a 49-year-old  woman,  who  was  initially  diagnosed  with  aeywords:
ntrapancreatic accessory spleen
ancreatic neuroendocrine tumor
iver hemangioma
etastasis
neuroendocrine  tumor  of the  pancreas  with  metastasis  to the  liver.  The  patient  underwent  distal  pancre-
atectomy  and  atypical  liver resection.  Surprisingly,  however,  histopathological  examination  revealed  an
intrapancreatic  accessory  spleen  (IPAS)  of the pancreatic  tail as well  as  liver  hemangioma.  This unique
case  report  highlights  the  impact  of extensive  preoperative  examinations  to  differentiate  benign and
malignant  pancreatic  lesions  and,  possibly,  prevent  patients  from  unnecessary  surgery.
© 2015  The  Authors.  Published  by Elsevier  Ltd.  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
Neuroendocrine carcinoma of the pancreas (panNET) represent
 rare tumor entity which amount for only 2% of all pancreatic neo-
lasms [1,2]. panNETs mainly develop in the pancreatic head and
bout 15–53% of patients suffering from panNETs become symp-
omatic due to hormone secretion such as insulin or gastrin [3].
he majority of all panNETs show malignant characteristics since
anNETs often metastasize to the liver [1]. Importantly, in 80% of
ll newly diagnosed panNETs multiple liver and/or extrahepatic
etastases are detected [4,5].
For tumor located in the pancreatic head a pancreaticoduo-
enectomy is performed in most cases. In contrast, for tumors
ocated in the pancreatic tail a distal pancreatectomy is the surgi-
al procedure of choice. Although a surgical approach is considered
henever a malignant, resectable and non-metastasized tumor
s suspected, histopathological examinations ultimately reveal a
enign diagnosis in 5–21% upon pancreaticoduodenectomies and
1% upon distal pancreatectomies [6–9].∗ Corresponding author. Fax: +49 731 500 53503.
E-mail address: doris.henne-bruns@uniklinik-ulm.de (D. Henne-Bruns).
ttp://dx.doi.org/10.1016/j.ijscr.2015.10.041
210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing G
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2. Case report
We report on a 49-year-old woman  with benign kidney cysts.
No additional preconditions were known and the patient was not
under any long-term medication. The patient underwent a follow-
up MRI  because of kidney cysts in 03/2014. Here, a tumor in the
pancreatic tail was  identiﬁed which initially showed characteristic
of a benign lesion. In a subsequent MRI  performed in 10/2014 the
lesion had increased in size and now presented with some radio-
logical features of a malignant tumor (Fig. 1). Therefore the patient
was admitted to our hospital for further examination. The patient
was asymptomatic and routine laboratory analysis did not show
any pathology, including normal CA 19-9. To further characterize
the pancreatic lesion a computed tomography (CT) of the abdomen
was performed. Here, the lesion showed radiological characteristics
of a neuroendocrine tumor (Fig. 2). Moreover, the CT scan revealed
a contrast-enhanced lesion of the liver for which malignancy could
not be excluded (Fig. 3).
In a subsequently performed endosonography the pancreas
showed no pathological signs and the pancreatic lesion could
not be identiﬁed excluding the possibility to obtain a biopsy.
To further characterize the pancreatic tumor a Dotatate PET-CT
was performed which revealed strong Tracer-uptake of the pan-
creatic lesion, strongly suggesting a neuroendocrine tumor of
the pancreatic tail (Fig. 4). Subsequently, the patient underwent
spleen-preserving distal pancreatectomy and atypical liver resec-
tion. Intraoperatively, the tumor presented as a soft lesion of dark
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Arterial phase of a T1 weighted MRI  showing an inhomogeneous contrast enhancement of a suspect lesion of the pancreatic tail.
Fig. 2. Arterial phase of a contrast-enhanced CT scan. Intrapancreatic 
Fig. 3. Arterial phase of a contrast-enhanced CT scan showing contrast enhance-
ment (arrow) of a liver lesion.tumor (arrow) showing inhomogeneous contrast enhancement.
color. Interestingly, intraoperatively performed histopathological
examination did not show malignant features of the pancreatic
tumor, which was the reason why  the spleen was  preserved.
The postoperative course of the patient was uneventful. Sur-
prisingly, the histopathological analysis revealed the pancreatic
lesion being an intrapancreatic accessory spleen (Fig. 5) and the
liver lesion being a hemangioma.
3. Discussion
Accessory spleens originate from a congenital failure of splenic
bud fusion during embryogenesis [10]. This abnormality is detected
in about 10–30% in autopsies. In most cases accessory spleens are
located at the splenic hilum. Interestingly, CT scans reveal asymp-
tomatic accessory spleens in 16% of patients undergoing CT scans of
the abdomen [11,12]. Although, intrapancreatic accessory spleens
can mimic  intrapancreatic tumors, such as neuroendocrine tumors
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Fig. 4. Dotatate PET-CT showing strong Tracer uptake in the suspect lesion of the pancreatic tail.
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Pig. 5. Histopathology of the resected pancreatic tissue: HE (A) staining suggesting
taining conﬁrming the benign diagnose of an accessory spleen of the pancreatic ta
13], up to date only a few cases of non-cystic intrapancreatic acces-
ory spleen have been reported in the literature.
In cases of panNETs presenting with synchronous liver metas-
ases surgery is usually considered in cases when complete surgical
esection of the primary tumor and the metastatic lesions appears
easible. In contrast, the diagnosis of asymptomatic IPAS does not
equire a surgical treatment [1,2]. This fact underlines the crucial
ecessity to provide adequate preoperative diagnostics to prevent
atients from unnecessary surgery.
In the presented case a metastatic panNET was  suspected pre-
peratively based on the MRI  and CT scan as well as on a Dotatate
ET-CT, which lead to unnecessary distal pancreatectomy.trapancreatic accessory spleen, B: immunohistopathological CD20 (B) and CD3 (C)
Interestingly it has been reported that IPAS can mimic
panNET in nuclear imaging, such as Dotatate PET-CT, due to
somatostatine-positivity of intrasplenic lymphocytes [15]. Non-
invasive differentiation between IPAS and panNET can be provided
by using 99mTc-sulphur-colloid or 99mTc-tagged heat-damaged
RBC Scintigraphy, due to selective phagocytosis by reticulum-
endothelial cells in the liver and spleen [16,17].
Furthermore the suspected diagnosis of panNET was  hardened
by CT-imaging, which showed a contrast-enhanced lesion of the
liver, for which malignancy could not be ruled out, which ﬁnally
lead to atypical liver resection. Postoperatively the histopathologi-
cal analysis revealed a liver hemangioma. Interestingly, it has been
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eported that sclerosed hemangioma can mimic  liver metastasis of
astrointestinal cancers [14].
In conclusion, we consider IPAS a relevant differential diagno-
is in patients with suspected panNET, which should be taken into
ccount before surgery is provided.
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